Ming-Hua Ren

480 total citations
30 papers, 346 citations indexed

About

Ming-Hua Ren is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming-Hua Ren has authored 30 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming-Hua Ren's work include Ferroptosis and cancer prognosis (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). Ming-Hua Ren is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). Ming-Hua Ren collaborates with scholars based in China, Singapore and Germany. Ming-Hua Ren's co-authors include Yaxuan Wang, Jianshe Wang, Cheng Zhang, Beichen Ding, Bo Ji, Shaobin Ni, Xiaoxiong Wang, Changlin Wang, Haoming Li and Jing Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ming-Hua Ren

30 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Hua Ren China 13 180 117 92 61 50 30 346
Longwang Wang China 12 263 1.5× 154 1.3× 114 1.2× 85 1.4× 32 0.6× 25 461
Chuanmin Chu China 14 251 1.4× 163 1.4× 150 1.6× 97 1.6× 85 1.7× 25 492
Benoît Vallée France 14 236 1.3× 155 1.3× 67 0.7× 70 1.1× 65 1.3× 19 486
Peiwei Zhao China 11 160 0.9× 79 0.7× 65 0.7× 23 0.4× 55 1.1× 34 362
Xiangyang Zeng China 8 225 1.3× 135 1.2× 174 1.9× 92 1.5× 101 2.0× 17 492
Lang Liu China 12 219 1.2× 82 0.7× 159 1.7× 40 0.7× 33 0.7× 33 370
Yuanjie Niu China 10 160 0.9× 146 1.2× 57 0.6× 50 0.8× 28 0.6× 22 342
Kuan-Chieh Wang Taiwan 13 131 0.7× 87 0.7× 44 0.5× 22 0.4× 74 1.5× 17 362
Daohu Wang China 11 181 1.0× 90 0.8× 86 0.9× 70 1.1× 43 0.9× 32 399

Countries citing papers authored by Ming-Hua Ren

Since Specialization
Citations

This map shows the geographic impact of Ming-Hua Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Hua Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Hua Ren more than expected).

Fields of papers citing papers by Ming-Hua Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Hua Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Hua Ren. The network helps show where Ming-Hua Ren may publish in the future.

Co-authorship network of co-authors of Ming-Hua Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Hua Ren. A scholar is included among the top collaborators of Ming-Hua Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Hua Ren. Ming-Hua Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jingjing, et al.. (2025). Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment. Frontiers in Immunology. 16. 1623859–1623859. 3 indexed citations
2.
Wang, Yaxuan, Jinfeng Wang, Lu Zhang, et al.. (2024). Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target. Journal of Cellular and Molecular Medicine. 28(7). 1–20. 22 indexed citations
3.
Wang, Yaxuan, Haixia Zhu, Lu Zhang, et al.. (2024). Common immunological and prognostic features of lung and bladder cancer via smoking‐related genes: PRR11 gene as potential immunotherapeutic target. Journal of Cellular and Molecular Medicine. 28(10). e18384–e18384. 12 indexed citations
4.
5.
Wang, Jianshe, Yaxuan Wang, Bo Ji, et al.. (2024). JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation. SHILAP Revista de lepidopterología. 24(4). 897–911. 23 indexed citations
6.
Wang, Changlin, et al.. (2023). Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. Journal of Clinical Medicine. 12(5). 1861–1861. 2 indexed citations
7.
Tang, Ruhang, Zhibo Xie, Xiangyan Ruan, et al.. (2023). Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol. Climacteric. 27(2). 171–177. 3 indexed citations
8.
Wang, Yaxuan, et al.. (2023). Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer. Frontiers in Immunology. 14. 1289198–1289198. 26 indexed citations
9.
Liu, Yang, Bo Ji, Jinfeng Wang, et al.. (2023). Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer. Aging. 15(20). 11369–11388. 3 indexed citations
10.
Liu, Yang, Jianshe Wang, Jinfeng Wang, et al.. (2023). Heat shock protein family A member 8 is a prognostic marker for bladder cancer: Evidences based on experiments and machine learning. Journal of Cellular and Molecular Medicine. 27(24). 3995–4008. 5 indexed citations
11.
Liu, Yang, et al.. (2022). The predictive value of pyroptosis for the prognosis and immune escape of bladder cancer.. PubMed. 14(11). 7744–7757. 1 indexed citations
12.
Song, Yimin, Ming-Hua Ren, Yadong Wu, et al.. (2019). The effect of different surface treatment methods on the physical, chemical and biological performances of a PGA scaffold. RSC Advances. 9(35). 20174–20184. 20 indexed citations
13.
Wang, Changlin, Gang Wang, Zijian Zhang, et al.. (2018). The downregulated long noncoding RNA <em>DHRS4-AS1</em> is protumoral and associated with the prognosis of clear cell renal cell carcinoma. OncoTargets and Therapy. Volume 11. 5631–5646. 16 indexed citations
14.
Wang, Changlin, Jing Liu, Gang Wang, et al.. (2017). MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression. Cellular Physiology and Biochemistry. 43(6). 2405–2419. 47 indexed citations
15.
Wang, Gang, Daming Zhang, Jing Liu, et al.. (2017). Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity. Chinese Medical Journal. 130(18). 2176–2182. 1 indexed citations
16.
Ren, Ming-Hua, Yafei Zhou, Hua Chen, et al.. (2017). Quantitative analysis of multiple elements in healthy and remodeled epithelium from human upper airway mucosa using nuclear microscopy. Allergy. 73(3). 724–727. 7 indexed citations
17.
Ren, Ming-Hua, Erlin Song, Cheng Zhang, et al.. (2013). Antitumor effects of mutant endostatin are enhanced by Bcl-2 antisense oligonucleotides in UM-UC-3 bladder cancer cell line.. PubMed. 126(15). 2834–9. 2 indexed citations
18.
Hong, David S., Razelle Kurzrock, Neil Senzer, et al.. (2010). Phase I dose-escalation study of E7080, a selective tyrosine kinase inhibitor, administered orally to patients with solid tumors.. Journal of Clinical Oncology. 28(15_suppl). 2540–2540. 12 indexed citations
19.
Xu, Wanhai, Cheng Zhang, Weiming Zhao, et al.. (2009). Mutational analysis of proto-oncogene Dbl on Xq27 in testicular germ cell tumors reveals a rare SNP in a patient with bilateral undescended testis. World Journal of Urology. 27(6). 811–815. 2 indexed citations
20.
Ren, Ming-Hua. (2005). Study on Purification and Biological Activity of Recombinant Human Endostatin. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longwang Wang Breakdown of academic impact, for papers by Chuanmin Chu Breakdown of academic impact, for papers by Benoît Vallée Breakdown of academic impact, for papers by Peiwei Zhao Breakdown of academic impact, for papers by Xiangyang Zeng Breakdown of academic impact, for papers by Lang Liu Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Kuan-Chieh Wang Breakdown of academic impact, for papers by Daohu Wang
Rankless by CCL
2026